Home/Pipeline/Inhaled Tuberculosis Vaccine (Ad5 Vector)

Inhaled Tuberculosis Vaccine (Ad5 Vector)

TB Booster

Phase 2Active

Key Facts

Indication
TB Booster
Phase
Phase 2
Status
Active
Company

About CanSino Biologics

A leading Chinese vaccine developer leveraging adenovirus vector technology to create innovative vaccines for global infectious disease prevention.

View full company profile

Therapeutic Areas